Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 May;185(4):487-94.
doi: 10.1007/s00213-006-0336-0. Epub 2006 Mar 9.

Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration

Affiliations
Randomized Controlled Trial

Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute oral lorazepam administration

Nunzio Pomara et al. Psychopharmacology (Berl). 2006 May.

Abstract

Rationale: Retrograde facilitation (RF) refers to a paradoxical phenomenon in which recall of information presented before acute administration of agents generally associated with anterograde amnestic and sedative effects, such as benzodiazepines, is enhanced relative to a placebo condition. However, it is unclear whether this effect occurs in elderly individuals and if it is influenced by plasma drug levels, baseline cognitive function, or genetic factors such as the APOE e-4 allele, that may modulate drug-induced cognitive toxicity.

Objectives: To determine if acute oral doses of lorazepam (0.5 mg, 1 mg) produced RF in elderly individuals exposed to interference tasks, and the variables associated with RF.

Materials and methods: Sixty-four cognitively intact and highly educated (>12 years) older adults (mean age, 66.09 years) participated in a placebo-controlled double-blind crossover study. The Buschke Selective Reminding Test was used to assess RF and amnestic effects for verbal memory. Self-ratings of mood states were also obtained.

Results: Lorazepam administration resulted in significant dose-dependent RF, i.e., better recall of pre-drug word lists compared to placebo [F(1,63)= 15.358; p<0.001 and F(1,63)= 46.163; p<0.001 for 0.5 and 1 mg lorazepam, respectively]. Also, more of the pre-drug words were recalled in the 1.0-mg-lorazepam condition relative to the 0.5-mg-lorazepam condition [F(1,63)=29.498; p<0.001]. In both the 0.5 and 1 mg lorazepam conditions, participants who exhibited high RF experienced significantly greater lorazepam-induced memory impairments over time [F(3,61)=2.901; p<0.05; F(3,61)=2.698; p<0.05; 0.5 and 1 mg lorazepam, respectively]. Also, in the 1-mg-lorazepam condition, participants who exhibited high RF reported significantly greater drowsiness relative to participants who showed less RF [t(62)=-2.521; p<0.05]. RF was not significantly associated with age, the APOE epsilon4 allele, years of education, global cognitive status, vocabulary scores, or a memory index score.

Conclusion: In healthy elderly, acute oral lorazepam administration resulted in dose-dependent RF, which was associated with greater anterograde amnestic and sedative effects.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurology. 1999 Jan 15;52(2):244-8 - PubMed
    1. Arch Gen Psychiatry. 2005 Feb;62(2):209-16 - PubMed
    1. Neurology. 2002 Sep 10;59(5):746-8 - PubMed
    1. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3334-9 - PubMed
    1. Ann Neurol. 1996 Jul;40(1):55-66 - PubMed

Publication types

LinkOut - more resources